Quarterly Result14 Feb 2026, 08:02 pm
ANG Lifesciences India Ltd Reports Q3 and Nine-Month Unaudited Financial Results for the Period Ended 31 Dec, 2025
AI Summary
ANG Lifesciences India Ltd has reported its unaudited financial results for the quarter and nine months ended on 31 Dec, 2025. The company's revenue from operations for the nine-month period stood at ₹ 6,880.44 lakhs, with a net loss of ₹ 1,034.29 lakhs. The company's standalone and consolidated financial results were approved in a board meeting on 14 Feb, 2026. Khurana Sharma & Co., the statutory auditors, issued a limited review report on the financial results.
Key Highlights
- ANG Lifesciences India Ltd reported unaudited financial results for Q3 and nine months ended on 31 Dec, 2025.
- Revenue from operations for the nine-month period was ₹ 6,880.44 lakhs.
- Net loss for the nine-month period was ₹ 1,034.29 lakhs.
- Standalone and consolidated financial results were approved in a board meeting on 14 Feb, 2026.
- Limited review report issued by statutory auditors Khurana Sharma & Co.
Price Impact
More from ANG